Related Experiment Video

Updated: Aug 15, 2026

Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus
06:55

Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus

Published on: December 5, 2015

Prostacyclin from the uterus and woman's cardiovascular advantage

J D Shelton

    Prostaglandins, Leukotrienes, and Medicine
    |May 1, 1982
    PubMed

    Insights

    Uterine prostacyclin may protect women from heart disease. Hysterectomy increases heart attack risk, suggesting the uterus plays a key role in cardiovascular health.

    Area of Science:

    • Cardiovascular Science
    • Endocrinology
    • Reproductive Biology

    Background:

    • Women exhibit a reduced risk of coronary heart disease compared to men.
    • The uterus is increasingly recognized as a systemically active organ.

    Purpose of the Study:

    • To investigate the hypothesis that uterine prostacyclin contributes to women's lower risk of coronary disease.
    • To explore the implications of uterine prostacyclin levels for cardiovascular health and disease prevention.

    Main Methods:

    • Review of epidemiologic data linking hysterectomy to increased myocardial infarction risk.
    • Comparison of circulating prostacyclin levels between premenopausal women and men.
    • Analysis of prostacyclin production by uterine tissue homogenates.
    • Measurement of prostacyclin metabolite levels in uterine venous drainage.

    Main Results:

    • Epidemiologic evidence indicates hysterectomy significantly elevates myocardial infarction risk.
    • Premenopausal women may possess higher circulating prostacyclin levels than age-matched men.
    • Uterine tissue demonstrates prostacyclin production capabilities.
    • High levels of a prostacyclin metabolite are found in uterine venous blood.

    Conclusions:

    • Prostacyclin from the uterus is a potential factor in women's reduced coronary disease risk.
    • Uterine removal (hysterectomy) is associated with increased subsequent myocardial infarction risk.
    • Understanding the uterus's systemic role offers therapeutic and preventive insights for cardiovascular disease.

    More Related Videos

    Biaxial Basal Tone and Passive Testing of the Murine Reproductive System Using a Pressure Myograph09:59

    Biaxial Basal Tone and Passive Testing of the Murine Reproductive System Using a Pressure Myograph

    Published on: August 13, 2019

    Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model06:49

    Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model

    Published on: April 7, 2023

    Related Concept Videos

    Fetal Circulation01:14

    Fetal Circulation

    Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
    Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

    Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
    These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
    Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

    Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

    The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
    Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
    Birth Control Methods01:22

    Birth Control Methods

    Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
    Intrauterine Drug Delivery Systems01:21

    Intrauterine Drug Delivery Systems

    Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
    Mitral Valve Prolapse III: Nursing Management01:19

    Mitral Valve Prolapse III: Nursing Management

    The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...